KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Interest Expenses (2017 - 2025)

Historic Interest Expenses for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $943000.0.

  • Guardant Health's Interest Expenses rose 4597.52% to $943000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 3025.96%. This contributed to the annual value of $2.6 million for FY2024, which is 11.64% up from last year.
  • Guardant Health's Interest Expenses amounted to $943000.0 in Q3 2025, which was up 4597.52% from $983000.0 recorded in Q2 2025.
  • Guardant Health's Interest Expenses' 5-year high stood at $983000.0 during Q2 2025, with a 5-year trough of $643000.0 in Q4 2021.
  • For the 5-year period, Guardant Health's Interest Expenses averaged around $685789.5, with its median value being $645000.0 (2022).
  • Within the past 5 years, the most significant YoY rise in Guardant Health's Interest Expenses was 795000.0% (2021), while the steepest drop was 8642.31% (2021).
  • Over the past 5 years, Guardant Health's Interest Expenses (Quarter) stood at $643000.0 in 2021, then grew by 0.16% to $644000.0 in 2022, then increased by 0.16% to $645000.0 in 2023, then changed by 0.0% to $645000.0 in 2024, then skyrocketed by 46.2% to $943000.0 in 2025.
  • Its last three reported values are $943000.0 in Q3 2025, $983000.0 for Q2 2025, and $791000.0 during Q1 2025.